
Adze Biotechnology Announces Orphan Drug Designation Granted to Adze-1.17-CD40L for the treatment of Malignant Glioma
Adze-1.17-CD40L is a systemically deliverable, conditionally replicative oncolytic virus that delivers recombinent human CD40 ligand locally into solid tumors. CORAL GABLES, FLORIDA, UNITED STATES, February 7, 2023 /EINPresswire.com/ -- Adze …